Literature DB >> 26343506

Small interfering RNA delivery by polyethylenimine-functionalised porous silicon nanoparticles.

M Hasanzadeh Kafshgari1, M Alnakhli, B Delalat, S Apostolou, F J Harding, E Mäkilä, J J Salonen, B J Kuss, N H Voelcker.   

Abstract

In this study, thermally hydrocarbonised porous silicon nanoparticles (THCpSiNPs) capped with polyethylenimine (PEI) were fabricated, and their potential for small interfering RNA (siRNA) delivery was investigated in an in vitro glioblastoma model. PEI coating following siRNA loading enhanced the sustained release of siRNA, and suppressed burst release effects. The positively-charged surface improved the internalisation of the nanoparticles across the cell membrane. THCpSiNP-mediated siRNA delivery reduced mRNA expression of the MRP1 gene, linked to the resistence of glioblastoma to chemotherapy, by 63% and reduced MRP1-protein levels by 70%. MRP1 siRNA loaded nanoparticles did not induce cytotoxicity in glioblastoma cells, but markedly reduced cell proliferation. In summary, the results demonstrated that non-cytotoxic cationic THCpSiNPs are promising vehicles for therapeutic siRNA delivery.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26343506     DOI: 10.1039/c5bm00204d

Source DB:  PubMed          Journal:  Biomater Sci        ISSN: 2047-4830            Impact factor:   6.843


  5 in total

Review 1.  Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery.

Authors:  Byungji Kim; Ji-Ho Park; Michael J Sailor
Journal:  Adv Mater       Date:  2019-09-30       Impact factor: 30.849

Review 2.  Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases.

Authors:  Meihua Luo; Leo Kit Cheung Lee; Bo Peng; Chung Hang Jonathan Choi; Wing Yin Tong; Nicolas H Voelcker
Journal:  Adv Sci (Weinh)       Date:  2022-07-18       Impact factor: 17.521

3.  Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma.

Authors:  Wing Yin Tong; Mohammed Alnakhli; Richa Bhardwaj; Sinoula Apostolou; Sougata Sinha; Cara Fraser; Tim Kuchel; Bryone Kuss; Nicolas H Voelcker
Journal:  J Nanobiotechnology       Date:  2018-04-13       Impact factor: 10.435

4.  RUNX1 (RUNX family transcription factor 1), a target of microRNA miR-128-3p, promotes temozolomide resistance in glioblastoma multiform by upregulating multidrug resistance-associated protein 1 (MRP1).

Authors:  Jianglong Xu; Jia Song; Menglin Xiao; Changsheng Wang; Qisong Zhang; Xiaoye Yuan; Shaohui Tian
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 5.  Functional Allele Validation by Gene Editing to Leverage the Wealth of Genetic Resources for Crop Improvement.

Authors:  Michael J Thomson; Sudip Biswas; Nikolaos Tsakirpaloglou; Endang M Septiningsih
Journal:  Int J Mol Sci       Date:  2022-06-12       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.